754 Logo (Mirtazapine 30 mg)

Pill imprint 754 Logo has been identified as Mirtazapine 30 mg.

Mirtazapine is used in the treatment of insomnia; major depressive disorder; anxiety; depression; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 30 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mirtazapine

Imprint:

754 Logo

Strength:

30 mg

Color:

Beige

Size:

10.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Tetracyclic antidepressants

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Laboratories, Inc.

National Drug Code (NDC):

62037-0754

Inactive Ingredients:

silicon dioxide colloidal
crospovidone
hypromellose 2910 3cp
hypromellose 2910 6cp
hypromellose 2910 50cp
lactose monohydrate
magnesium stearate
polydextrose
polyethylene glycol
polyethylene glycol 400
polyethylene glycol 8000
pregelatinized starch
titanium dioxide
triacetin
ferric oxide yellow
ferric oxide red

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.